Results 61 to 70 of about 380,856 (149)

The mitogenic potential of heparin-binding epidermal growth factor in the human endometrium is mediated by the epidermal growth factor receptor and is modulated by tumor necrosis factor-alpha [PDF]

, 2002
Heparin-binding epidermal growth factor (HB-EGF), a member of the epidermal growth factor (EGF) family, is implicated in a variety of biological processes, including reproduction.
Mardon, Helen J., Yoo, Hyung-J, Katya Chobotova, Barlow, David, Helen J. Mardon, Carver, J, Chobotova, K, Muchmore, ME, William J. Gullick, Muchmore, Mary-Elizabeth, Chobotova, Katya, Janet Carver, Yoo, HJ, Hyung-J Yoo, David H. Barlow, Manek, Sanjiv, Sanjiv Manek, Manek, S, Barlow, DH, Mary-Elizabeth Muchmore, Gullick, WJ, Gullick, William J., Carver, Janet, Mardon, HJ   +23 more
core   +1 more source

Anti-Platelet Factor 4/Heparin Antibody Formation Occurs Endogenously and at Unexpected High Frequency in Polycythemia Vera [PDF]

, 2017
Background.Myeloproliferative neoplasms (MPN) encounter thromboses due to multiple known risk factors. Heparin-induced thrombocytopenia (HIT) is a thrombotic syndrome mediated by anti-platelet factor 4 (PF4)/heparin antibodies with undetermined ...
Tsakiris, Dimitrios A, Sara C. Meyer, Eva Steinmann, Skoda, Radek C, Muesser, Patricia, Steinmann, Eva, Patricia Muesser, Meyer, Sara C., Thomas Lehmann, Passweg, Jakob R, Dimitrios A. Tsakiris, Lehmann, Thomas, Jakob R. Passweg, Radek C. Skoda, Steinmann E, Passweg JR, Tsakiris DA, Skoda RC, Lehmann T, Meyer SC, Muesser P   +20 more
core   +2 more sources

Chemistry and biology of heparin and heparan sulfate /

, 2005
The chemistry, biochemistry and pharmacology of heparin and heparan sulfate have been and continue to be a major scientific undertaking - heparin and its derivative remain important drugs in clinical practice. Chemistry and Biology of Heparin and Heparan
Garg, Hari G., Linhardt, Robert J., Hales, Charles A.   +2 more
core  

Heparin releases newly synthesized cell surface-associated apolipoprotein E from HepG2 cells.

Journal of Lipid Research, 1993
Heparin significantly increased the amount of newly synthesized apolipoprotein E (apoE) released by HepG2 cells. Culturing cells in the presence of 10 micrograms/ml of heparin for 2-6 days caused a 1.3-fold (day 2) to 3-fold (day 6) increase of ...
M Lilly-Stauderman, TL Brown, A Balasubramaniam, JA Harmony   +3 more
doaj   +1 more source

Immobilization of Naio4-Treated Heparin on Peg-Modified 316l Ss Surface for High Anti-Thrombin-Iii Binding

, 2009
Poor compatibility between blood and metallic coronary artery stents is one reason for arterial restenosis; however , the immobilization of anticoagulant agents on the surface of the stent is a feasible method of improving stent compatibility. Heparin, a
CHUANG, TZU-WEN;LIN, DONG-TSAMN;LIN, FENG-HUEI, 莊子文;林東燦;林峰輝   +1 more
core  

Surface Characterization and Hemocompatibility of Heparinized 316l Stainless Steel

, 2009
Poor compatibility between blood and metallic coronary artery stents is one reason for arterial restenosis. Immobilization of heparin on stent's surface is feasible for improving compatibility.
莊子文;林峰輝, CHUANG, TZU-WEN;LIN, FENG-HUEI   +1 more
core   +1 more source

The variable use of heparin through intravenous bolus and flush fluid systems during endovascular stroke treatment, a world-wide survey

CVIR Endovascular
Background The total amount of heparin administered through flush fluids in stroke patients is not considered in recent trials, possibly influencing main results. We investigated the use of heparin among treating physicians worldwide.
Senta Frol, Faysal Benali, Aymeric Rouchaud, Robrecht R. M. M. Knapen, Wim H. van Zwam, Research Committee of the European Society of Minimally Invasive Neurological Therapy (ESMINT)   +5 more
doaj   +1 more source

Anticoagulation management for cardiopulmonary bypass using TEG® 6 s in a patient receiving both heparin and dabigatran

JA Clinical Reports
Background It is difficult to evaluate adequate dose of heparin for cardiopulmonary bypass (CPB) by activated clotting time (ACT) in a patient receiving both heparin and dabigatran because dabigatran can also prolong ACT.
Yu Kawada, Nobuyuki Katori, Keiko Kaji, Shoko Fujioka, Tomoki Yamaguchi   +4 more
doaj   +1 more source

Further characterization of the binding of heparin to granulocyte colony-stimulating factor: Importance of sulfate groups

, 2008
Heparin mediates fundamental biological mechanisms through interaction with proteins. Previously, we have shown that standard heparin binds to granulocyte colony-stimulating factor (G-CSF) with an affinity of 4.8 x 10(5) M-1.
林炳承, Wang, Keyi, Liu, Xiaojun, Du, Yuguang, Liang, Aiye, Lin, Bingcheng   +5 more
core   +1 more source

Proteomic Identification and Functional Analysis of Babesia microti Reveals Heparin-Binding Proteins

Journal of Tropical Medicine
Glycosaminoglycan (GAG) molecules on the surface of red blood cells play an important regulatory role in the invasion of merozoites of apicomplexan protozoa.
Yu Chun Cai, Bin Xu, Yan Hong Chu, Ying Fang Yu, Jia Hui Sun, Zi Ran Mo, Han Yin Yang, Shu Ning Yan, Mu Xin Chen, Jia Xu Chen   +9 more
doaj   +1 more source